Deal offers units of one common share, one warrant at C$1.46 per unit
By Devika Patel
Knoxville, Tenn., July 29– Helix BioPharma Corp. said it raised about C$1.8 million in a private placement of units.
The company sold units of one common share and one warrant at C$1.46 per unit.
Each five-year warrant will be exercisable at C$1.82, a 9% discount to the July 28 closing share price of C$2.00.
Proceeds will be used for working capital, new immuno-oncology projects and clinical development programs.
Helix BioPharma is an Aurora, Ont., biopharmaceutical company developing products for the treatment of cancer and pre-cancerous conditions.
| Issuer: | Helix BioPharma Corp.
|
| Issue: | Units of one common share and one warrant
|
| Amount: | C$1.8 million (approximate)
|
| Price: | C$1.46
|
| Warrants: | One warrant per unit
|
| Warrant expiration: | Five years
|
| Warrant strike price: | C$1.82
|
| Settlement date: | July 29
|
| Stock symbol: | Toronto: HBP
|
| Stock price: | C$2.00 at close July 28
|
| Market capitalization: | C$175.84 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
